Ulcerative Colitis Clinical Trials in Hershey, Pennsylvania

3 studies are recruiting for ulcerative colitis in Hershey, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

    This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis (UC). Study details include: The study duration may be up to 35 weeks wi…

    Stage
    Phase 3
    Ages
    16 to 80
    Site
    Penn State Milton S. Hershey Medical Center - Site Number: 8400066, Hershey, Pennsylvania
    Locations
    219 in total
    Run by
    Sanofi

    See if you can join NCT07184996 on ClinicalTrials.gov

  2. A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

    The main aim of this study is to learn how the body of a child or teenager with moderately to severely active ulcerative colitis (UC) or Crohn's disease (CD) processes vedolizumab (pharmacokinetics) given just under the skin subcutaneously (SC). The participants will be treated with vedolizumab for…

    Stage
    Phase 3
    Ages
    2 to 17
    Site
    Penn State Health Milton S. Hershey Medical Center/ Penn State University College of Medicine, Hershey, Pennsylvania
    Locations
    54 in total
    Run by
    Takeda

    See if you can join NCT06100289 on ClinicalTrials.gov

  3. A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

    The main aim of this study is to learn about medical problems (adverse events) if vedolizumab subcutaneously (SC) is given to a child or teenager with UC or CD for a long time. Other aims are to understand if the long time use of vedolizumab SC has an impact on the time period until hospital visits…

    Stage
    Phase 3
    Ages
    2 to 17
    Site
    Penn State Health Milton South Hershey Medical Center, Hershey, Pennsylvania
    Locations
    54 in total
    Run by
    Takeda

    See if you can join NCT06405087 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.